Prophylaxis of necrotizing enterocolitis by oral IgA-IgG: review of a clinical study in low birth weight infants and discussion of the pathogenic role of infection.

Abstract

Necrotizing enterocolitis, a severe gastrointestinal disease in the neonatal period, affects primarily premature infants. Perinatal complications that predispose the neonate to systemic hypoxia are frequent in infants with necrotizing enterocolitis. Ischemia of the intestinal mucosa may facilitate the invasion of enteric microorganisms in stressed low birth weight infants. Geographical and temporal clustering of outbreaks of the disease and the termination of epidemics by standard infection control underline the importance of infectious agents in the development of this disease. Several studies have established the immunoprotective effect of orally administered antibodies against infection of the gastrointestinal mucosa in children and adults. Anecdotal evidence suggested that feeding of human immune globulin might have a positive effect on the incidence of necrotizing enterocolitis in premature infants. This paper reviews a prospective, randomized, controlled trial of the efficacy of an oral immune globulin preparation (published in detail in the New England Journal of Medicine, Vol. 319, pp 1-7, 1988) and discusses the pathogenic role of infection in necrotizing enterocolitis.

• Authors: M M Eibl, H M Wolf, H Fürnkranz, A Rosenkranz
• Journal: Journal of clinical immunology (J Clin Immunol) Vol. 10 Issue 6 Suppl Pg. 72S-77S; discussion 77S-79S (Nov 1990) ISSN: 0271-9142 [Print] Netherlands
• PMID: 2081793 (Publication Type: Clinical Trial, Journal Article, Randomized Controlled Trial, Review)

Chemical References

• Immunoglobulin A
• Immunoglobulin G

Topics

• Administration, Oral
• Enterocolitis, Pseudomembranous (microbiology, prevention & control)
• Humans
• Immunoglobulin A (analysis, therapeutic use)
• Immunoglobulin G (analysis, therapeutic use)
• Infant, Low Birth Weight
• Infant, Newborn
• Prospective Studies